Skip to main content

HEALTH

  • CDC: Awareness of prediabetes rose slightly in 2009-2010

    ATLANTA — The percentage of people who are at risk of developing Type 2 diabetes and aware of it has risen slightly over the past few years, but remains low, according to a report by the Centers for Disease Control and Prevention.

  • SoloHealth fills new role of director of business planning and analytics

    ATLANTA — SoloHealth on Friday named Joe Stephens to the newly created role of director of business planning and analytics. Stephens will focus on organizing business development initiatives, priorities, metrics and efficiencies, as well as helping guide new-business exploration as the company continues its growth. 

    Stephens will report directly to Stephen Kendig, chief commercial officer and EVP of SoloHealth, effective immediately.

  • SanMedica unveils new HGH-booster at Academy of Women's Health's Annual Congress

    WASHINGTON —  SanMedica International on Friday introduced its SeroVital-HGH, a new oral human-growth hormone booster formulated with women in mind, at the Academy of Women's Health's Annual Congress here. 

  • LifeScan recalls OneTouch VerioIQ blood-glucose meters

    MILPITAS, Calif. — LifeScan on Monday initiated a voluntary recall and replacement for all of its OneTouch VerioIQ blood-glucose meters in the United States, effective immediately.

  • Lilly, BI apply for diabetes drug approval

    RIDGEFIELD, Conn. — Boehringer Ingelheim and Eli Lilly are seeking regulatory approval for an experimental drug to treat Type 2 diabetes, the companies said Monday.

    BI and Lilly announced the submission of a regulatory application to the Food and Drug Administration for empagliflozin. The drug belongs to a new drug class known as SGLT2 inhibitors, which work by removing excess glucose through the urine by blocking its reabsorption in the kidneys. The companies are testing the drug in a late-stage clinical trial for which they plan to enroll 14,500 patients.

  • Senators introduce bill restricting sale of DXM cough-relieving ingredient to adults

    WASHINGTON — Sens. Bob Casey, D-Pa., and Lisa Murkowski, R-Ark., on Friday introduced the Preventing Abuse of Cough Treatments Act of 2013, which would require retailers to restrict the sale of dextromethorphan-containing products to adults. The bill also would restrict the sale of raw, bulk DXM to FDA-approved entities. 

    Many retailers have age restrictions on the sale of DXM products already in place; and similar legislation to this has been enforced in California since 2012. 

  • Hawaiian Punch says Aloha to the breakfast table

    PLANO, Texas — Dr Pepper Snapple Group announced today the new Hawaiian Punch Aloha Morning line of juice drinks to hit store shelves.

    The new Aloha Morning line provides a good source of vitamins A, C and E, and each variety contains 40% less sugar than other juice drinks. Hawaiian Punch Aloha Morning comes in three flavors: orange citrus, mixed berry citrus and strawberry citrus.

  • Boiron owner publishes homeopathy desktop reference

    NEWTOWN SQUARE, Pa. — Boiron owner Michèle Boiron recently published a book on homeopathy for healthcare professionals titled "Homeopathy and Pharmaceutical Care," the company announced. In April 2013, she and co-author François Roux will host lectures in Philadelphia and New York. 

X
This ad will auto-close in 10 seconds